The effect of organ-specific cd26/dpp iv enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection

Transplantation

Volumn 88, Issue 4, 2009, Pages 478-485

  Jungraithmayr, Wolfgang ^a   Oberreiter, Birgit ^a   De Meester, Ingrid ^b   Wiedl, Thomas ^a   Inci, Ilhan ^a   Bain, Martha ^a   Augustyns, Koen ^b   Hillinger, Sven ^a   Scharpé, Simon ^b   Weder, Walter ^a   Korom, Stephan ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acute rejection; Dipeptidylpeptidase IV; Lung transplantation; Vasoactive intestinal peptide

Indexed keywords

CYCLINE; CYCLOSPORIN; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; MESSENGER RNA; MYELOPEROXIDASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; LUNG ALVEOLUS MACROPHAGE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; RESPIRATORY EPITHELIUM;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD26; GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PEROXIDASE; PHOSPHONIC ACIDS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROLINE; PROTEASE INHIBITORS; RATS; RATS, INBRED BN; RATS, INBRED LEW; RNA, MESSENGER; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 70349089301     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b08e77     Document Type: Article

References (38)

1. Ikushima H, Munakata Y, Iwata S, et al. Soluble CD26/dipeptidyl pep-tidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cell Im-munol 2002; 215: 106.
2. De Meester I, Korom S, Van Damme J, et al. CD26, let it cut or cut it down. Immunol Today 1999; 20: 367.
3. Tanaka T, Kameoka J, Yaron A, et al. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 1993; 90: 4586.
4. Tanaka T, Duke-Cohan JS, Kameoka J, et al. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 1994; 91: 3082.
5. De Meester I, Durinx C, Bal G, et al. Natural substrates of dipeptidyl peptidase IV. Adv Exp Med Biol 2000; 477: 67.
6. Lambeir AM, Durinx C, Scharpe S, et al. Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003; 40: 209.
7. Linardi A, Panunto PC, Ferro ES, et al. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME). Biochem Pharmacol 2004; 68: 205.
8. Korom S, De Meester I, Stadlbauer TH, et al. Inhibition of CD26/ dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 1997; 63: 1495.
9. Jung FJ, Yang L, De Meester I, et al. CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats. J Heart Lung Transplant 2006; 25: 1109.
10. Zhai W, Cardell M, De Meester I, et al. Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. J Heart Lung Transplant 2007; 26: 174.
11. Mizuta T, Kawaguchi A, Nakahara K, et al. Simplified rat lung transplantation using a cuff technique. J Thorac Cardiovasc Surg 1989; 97: 578.
12. Belyaev A, Zhang X, Augustyns K, et al. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem 1999; 42: 1041.
13. Eppinger MJ, Jones ML, Deeb M, et al. Pattern of injury and the role of neutrophil in reperfusion injury in the rat lung. J Surg Res 1995; 58: 713.
14. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229.
15. Graf R, Schiesser M, Lussi A, et al. Coordinate regulation of secretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis. J Surg Res 2002; 105: 136.
16. Lasbury ME, Durant PJ, Bartlett MS, et al. Correlation of organism burden and alveolar macrophage counts during infection with Pneu-mocystis carinii and recovery. Clin Diagn Lab Immunol 2003; 10: 293.
17. Nagayasu T, Oka T, Sawada T, et al. Expression of proliferating cell nuclear antigen in bronchial epithelium after lung transplantation in the rat. J Heart Lung Transplant 1998; 17: 566.
18. Riise GC, Kjellstrom C, Ryd W, et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: A prospective, longitudinal study. Eur Respir J 1997; 10: 1742.
19. Sakakibara H, Shima K, Said SI. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am J Physiol 1994; 267: L256.
20. Ichikawa S, Sreedharan SP, Owen RL, et al. Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung. Am J Physiol 1995; 268: L584.
21. Thom M, Palmer A, Cattell V, et al. Proliferating cell nuclear antigen (PCNA) as a diagnostic marker of acute cellular rejection in routinely processed biopsies of renal allografts. Nephrol Dial Transplant 1994; 9: 153.
22. Pratley RE, Salsali A. Inhibition of DPP-4: A new therapeutic approach for the treatment of type 2 diabetes. Curr Med Res Opin 2007; 23: 919.
23. Nathanson I, Widdicombe JH, Barnes PJ. Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. J Appl Physiol 1983; 55: 1844.
24. Blalock JE. The immune system as the sixth sense. J Intern Med 2005; 257: 126.
25. Berisha HI, Bratut M, Bangale Y, et al. New evidence for transmitter role of VIP in the airways: Impaired relaxation by a catalytic antibody. Pulm Pharmacol Ther 2002; 15: 121.
26. Palmer JB, Cuss FM, Barnes PJ. VIP and PHM and their role in non-adrenergic inhibitory responses in isolated human airways. J Appl Physiol 1986; 61: 1322.
27. Saga T, Said SI. Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma. Trans As-soc Am Physicians 1984; 97: 304.
28. Said SI, Dickman KG. Pathways of inflammation and cell death in the lung: Modulation by vasoactive intestinal peptide. Regul Pept 2000; 93: 21.
29. Pozo D, Gonzalez-Rey E, Chorny A, et al. Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders. Peptides 2007; 28: 1833.
30. Said SI. The Viktor Mutt Memorial Lecture. Protection by VIP and related peptides against cell death and tissue injury. Ann N Y Acad Sci 2000; 921: 264.
31. Delgado M, Chorny A, Gonzalez-Rey E, et al. Vasoactive intestinal peptide generates CD4-CD25- regulatory T cells in vivo. J Leukoc Biol 2005; 78: 1327.
32. Lambeir AM, Durinx C, Proost P, et al. Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett 2001; 507: 327.
33. Zhu L, Tamvakopoulos C, Xie D, et al. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: In vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). J Biol Chem 2003; 278: 22418.
34. Baratin M, Bonin K, Daniel C. Frontline: Peripheral priming of allo-reactive T cells by the direct pathway of allorecognition. Eur J Immunol 2004; 34: 3305.
35. Ohnuma K, Munakata Y, Ishii T, et al. Soluble CD26/dipeptidyl pepti-dase IV induces T cell proliferation through CD86 up-regulation on APCs. J Immunol 2001; 167: 6745.
36. Alijagic S, Moller P, Artuc M, et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 1995; 25: 3100.
37. Gerli R, Muscat C, Bertotto A, et al. CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin Immunol Immunopathol 1996; 80: 31.
38. Van der Veken P, Soroka A, Brandt I, et al. Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates. J Med Chem 2007; 50: 5568.